Dietary Polysaccharides for Overweight and Obesity Management: Targeting AMPK via the Gut Microbiota and Metabolites—A Review

Clicks: 9
ID: 337670
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #48 of 50 articles by views in nutrition reviews

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Abstract Obesity arises from dietary energy intake–expenditure imbalance. 5'-Adenosine monophosphate–activated protein kinase (AMPK), a core regulator of biological energy metabolism, is a key target for obesity research and can be activated by endogenous stimuli, such as cellular stress and physical exercise. As natural active components with diverse sources and biological functions, dietary polysaccharides have shown potential lipid-lowering and antiobesity effects in preclinical studies. This narrative review systematically summarizes their structural characteristics, sources, absorption-utilization mechanisms and structure-activity relationships, focusing on their regulatory effects on obesity via the AMPK pathway. We searched PubMed and Web of Science for publications (2014–2026) using “dietary polysaccharides,”“AMPK,”“obesity,” and “gut microbiota” as key words, screening original studies and reviews relevant to the core topic. Correlative evidence suggests that dietary polysaccharides are associated with altered expression of lipid metabolism–related factors through potential modulation of gut microbiota and its metabolites, with indirect links to AMPK activation. Such AMPK regulatory effects have tissue/organ specificity, and the causal relationship of each link remains to be rigorously established. Notably, the majority of current evidence derives from in vitro and rodent models, and extrapolation to human obesity management requires caution, as high-quality human clinical trials are urgently needed to validate the translational potential of these preclinical findings. This review clarifies the potential mechanism and existing research gaps of dietary polysaccharides in obesity alleviation, providing a scientific basis for the research and development of lipid-lowering functional foods based on dietary polysaccharides.
Reference Key
openalex_W7224168538 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors
Journal nutrition reviews
Year 2026
DOI
10.1093/nutrit/nuag161
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.